Insulet
PODD
#1583
Rank
NZ$23.92 B
Marketcap
NZ$339.91
Share price
-1.40%
Change (1 day)
-14.51%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.03

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.92. In 2024 the company made an earnings per share (EPS) of NZ$10.12 an increase over its 2023 EPS that were of NZ$4.99.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.03-40.38%
2024NZ$10.12102.71%
2023NZ$4.994114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.19-38.89%
2019NZ$0.30200%
2018NZ$0.10-113.04%
2017NZ-$0.78-9.8%
2016NZ-$0.86-60.47%
2015NZ-$2.1838.71%
2014NZ-$1.5712.05%
2013NZ-$1.40-23.15%
2012NZ-$1.83-12.2%
2011NZ-$2.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.85 218.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.35 7.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.07 2.57%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$38.96 557.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.16-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ-$0.52-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.64-38.57%๐Ÿ‡บ๐Ÿ‡ธ USA